NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054075

Registered date:06/04/2024

Use of Lemborexant for Insomnia in Our Clinic: A Retrospective Study

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedInsomnia
Date of first enrollment2024/04/05
Target sample size1000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThis study evaluates the impact of Lemborexant treatment on patients' sleep latency, number of nocturnal awakenings, frequency of early morning awakenings, and sleep quality. Additionally, the efficacy of Lemborexant will be assessed using the Athens Insomnia Scale (AIS).
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1.Patients diagnosed with sleep disorders other than insomnia 2.Patients who were administered other insomnia medications or had their Lemborexant dosage changed within 4 weeks from the initial consultation

Related Information

Contact

public contact
Name Hinako Imamura
Address Yukinari building 7F, 1-8-1, Shinmachi, Nishi-ku, Osaka-Shi, Osaka Japan 550013
Telephone 0666848552
E-mail info@wellness-general.jp
Affiliation Wellness General Clinic Wellness General Clinic
scientific contact
Name Rui Hioki
Address Yukinari building 7F, 1-8-1, Shinmachi, Nishi-ku, Osaka-Shi, Osaka Japan
Telephone 0666848552
E-mail info@wellness-general.jp
Affiliation Wellness General Clinic Wellness General Clinic